Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) just unveiled an update.
Epsilon Healthcare Limited reported a record-breaking quarter with customer receipts reaching $2.919 million, marking a 126% year-on-year growth. This significant financial performance highlights the company’s successful turnaround and strategic growth following its emergence from voluntary administration in mid-2024. The expansion of Epsilon’s pharmacy operations and the sale and leaseback of its Southport property have improved financial flexibility, positioning the company for continued growth and profitability. The company’s divisions, including Epsilon Pharma, Epsilon Clinics, and the newly launched Epsilon Pharmacy, have all contributed to this robust performance, showcasing Epsilon’s integrated healthcare ecosystem and its commitment to quality and patient care.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited operates in the healthcare industry, focusing on contract development and manufacturing, clinics, and pharmacy operations. The company is known for its pharmaceutical and natural therapies, with a market focus on quality, reliability, and patient-centric care.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
For a thorough assessment of EPN stock, go to TipRanks’ Stock Analysis page.